Frequent HPV-independent overexpression of p16Ink4a in head and neck carcinomas has been explained by mutation or amplification of CDKN2A or by mutations in RB1 or histone H3 lysine 36 methyltransferase genes [19]. This evidence concerns the gene CDKN2A and head and neck carcinoma.